Skip to content

Medical Affairs

Intelligence Hub

Overview

Home
My Work
Command Center

Plan & execute

Medical Plans
Launch Readiness
Budget & Resources
Risks & Decisions

Field & science

Engagements
Insights
Evidence Generation

Communicate

Publications
Congresses
Medical Information

Govern

Reports
Data Quality
Administration

Helixor Therapeutics

Sample data · FY2026

Scope·4 products·FY2026

HODr. Helen OkaforGlobal Head of Medical Affairs

EngagementsENG-0206

Scientific exchange · Dr. Ingrid Petit

25 Apr 2026 · Phone · Dr. Ingrid Petit, LMU Klinikum München · MSL James Whitfield · Lumeva

ReviewedVeeva CRMENG-0206—

Capture insight from this engagement

Location: LMU Klinikum München
Therapeutic area: Neurology
Country: Germany
Stakeholder tier: Tier 3
Strategic objective: Not linked
Initiative: Not linked
MSL: JWJames WhitfieldSenior MSL, Oncology (US East)
Product: Lumeva (lumevarin)

Topics discussed

Medication-overuse headache
Real-world persistence

Scientific content used

CGRP class review
Chronic migraine scientific platform

Questions raised

Any data in patients with medication-overuse headache?
Is there guidance on switching from a monoclonal antibody?

Notes

Scientific exchange with headache specialist at LMU Klinikum München. Discussed medication-overuse headache, real-world persistence.

Insights captured (1)

Capture insight

INS-0036Medium
Medication-overuse headache
Medication-overuse headache: request for data reported by headache specialist (DE).
Archived

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

Connect with Clinical Development

0 of 1 complete

Quality ratings

1–5, rated at review

Scientific relevance: 5
Strategic relevance: 5
Depth of exchange: 3
Actionability: 4

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0206

Audit history (0)

All create, update and approval events for this record

No audit events in sample data